Cationic contrast agents improve quantification of glycosaminoglycan (GAG) content by contrast enhanced CT imaging of cartilage

Journal of Orthopaedic Research

Volumn 29, Issue 5, 2011, Pages 704-709

  Bansal, Prashant N ^a,c   Joshi, Neel S ^b   Entezari, Vahid ^c   Malone, Bethany C ^b   Stewart, Rachel C ^a   Snyder, Brian D ^c   Grinstaff, Mark W ^a,b  

^a Boston University   (United States)

^b USA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cationic; computed tomography (CT); contrast agent; glycosaminoglycans (GAGs); proteoglycans

Indexed keywords

GLYCOSAMINOGLYCAN; IODINATED CONTRAST MEDIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARTILAGE; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATIONAL STUDY; COW; DEGRADATION; DIFFUSION; EXPERIMENTAL RABBIT; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; TISSUE DISTRIBUTION;

ANIMALS; BENZAMIDES; CARTILAGE, ARTICULAR; CATIONS; CATTLE; CONTRAST MEDIA; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; RABBITS; TOMOGRAPHY, X-RAY COMPUTED; TRIIODOBENZOIC ACIDS;

EID: 79952781643     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21312     Document Type: Article

References (38)

1. Felson DT, Lawrence RC, Dieppe PA, et al. 2000. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 133: 635-646.
2. Read SJ, Dray A., 2008. Osteoarthritic pain: a review of current, theoretical and emerging therapeutics. Expert Opin Investig Drugs 17: 619-640. (Pubitemid 351858385)
3. Goldring SR., 2009. Needs and opportunities in the assessment and treatment of osteoarthritis of the knee and hip: the view of the rheumatologist. J Bone Joint Surg Am 91: 4-6.
4. Block JA, Shakoor N., 2009. The biomechanics of osteoarthritis: implications for therapy. Curr Rheumatol Rep 11: 15-22.
5. Buckwalter KA., 2006. CT Arthrography. Clin Sports Med 25: 899-915. (Pubitemid 44311288)
6. Brandt KD., 1989. Pain, synovitis, and articular cartilage changes in osteoarthritis. Semin Arthritis Rheum 18: 77-80. (Pubitemid 19147652)
7. Kneeland JB, Reddy R., 2007. Frontiers in musculoskeletal MRI: articular cartilage. J Magn Reson Imaging 25: 339-344. (Pubitemid 46204583)
8. Recht MP, Goodwin DW, Winalski CS, et al. 2005. MRI of articular cartilage: revisiting current status and future directions. AJR Am J Roentgenol 185: 899-914.
9. Jaramillo D., 2008. Cartilage Imaging. Pediatr Radiol 38: S256-S258. (Pubitemid 351521167)
10. Wheaton AJ, Borthakur A, Kneeland JB, et al. 2004. In vivo quantification of T1rho using a multislice spin-lock pulse sequence. Magn Reson Med 52: 1453-1458. (Pubitemid 39612837)
11. Cockman MD, Blanton CA, Chmielewski PA, et al. 2006. Quantitative imaging of proteoglycan in cartilage using a gadolinium probe and microCT. Osteoarthritis Cartilage 14: 210-214. (Pubitemid 43329529)
12. Palmer AW, Gulberg RE, Levenston ME., 2006. Analysis of cartilage matrix fixed charge density and three-dimensional morphology via contrast-enhanced microcomputed tomography. Proc Natl Acad Sci USA 103: 19255-19260. (Pubitemid 46026020)
13. Winalski CS, Shortkroff S, Schneider E, et al. 2008. Targeted dendrimer-based contrast agents for articular cartilage assessment by MR imaging. Osteoarthritis Cartilage 16: 815-822.
14. Piscaer TM, Waarsing JH, Kops N, et al. 2008. In vivo imaging of cartilage degeneration using microCT-arthrography. Osteoarthritis Cartilage 16: 1011-1017.
15. Bacic G, Liu KJ, Goda F, et al. 1997. MRI contrast enhanced study of cartilage proteoglycan degradation in the rabbit knee. Magn Reson Med 37: 764-768. (Pubitemid 27187817)
16. Bashir A, Gray ML, Hartke J, et al. 1999. Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI. Magn Reson Med 41: 857-865. (Pubitemid 29211125)
17. Bashir A, Gray ML, Burstein D., 1996. Gd-DTPA2-as a measure of cartilage degradation. Magn Reson Med 36: 665-673.
18. Eckstein F, Wyman BT, Buck RJ, et al. 2009. Longitudinal quantitative MR imaging of cartilage morphology in the presence of gadopentetate dimeglumine (Gd-DTPA). Magn Reson Med 61.
19. Ling W, Regatte RR, Navon G, et al. 2008. Assessment of glycosaminoglycan concentration in vivo by chemical exchange-dependent saturation transfer. Proc Natl Acad Sci USA 105: 2266-2270. (Pubitemid 351520501)
20. Mamisch TC, Dudda M, Hughes T, et al. 2008. Comparison of delayed gadolinium enhanced MRI of cartilage (dGEMRIC) using inversion recovery and fast T1 mapping sequences. Magn Reson Med 60: 768-773.
21. Trattnig S, Domayer S, Welsch GW, et al. 2009. MR imaging of cartilage and its repair in the knee-a review. Eur Radiol 19: 1582-1592.
22. Taylor C, Carballido-Gamio J, Majumdar S, et al. 2009. Comparison of quantitative imaging of cartilage for osteoarthritis: T2, T1rho, dGEMRIC and contrast-enhanced computed tomography. Magn Reson Imaging 27: 779-784.
23. Sanz R, Martí-Bonmatí L, Rodrigo JL, et al. 2008. MR pharmacokinetic modeling of the patellar cartilage differentiates normal from pathological conditions. J Magn Reson Imaging 27: 171-177.
24. Wheaton AJ, Borthakur A, Shapiro EM, et al. 2004. Proteoglycan loss in human knee cartilage: quantitation with sodium MR imaging-feasibility study. Radiology 231: 900-905. (Pubitemid 38668115)
25. Wheaton AJ, Dodge GR, Elliott DM, et al. 2005. Quantification of cartilage biomechanical and biochemical properties via T1rho magnetic resonance imaging. Magn Reson Med 54: 1087-1093. (Pubitemid 41567186)
26. Staroswiecki E, Bangerter NK, Gurney PT, et al. 2010. In vivo sodium imaging of human patellar cartilage with a 3D cones sequence at 3 T and 7 T. J Magn Reson Imaging 32: 446-451.
27. Kallioniemi AS, Jurvelin JS, Nieminen MT, et al. 2007. Contrast agent enhanced pQCT of articular cartilage. Phys Med Biol 52: 1209-1219. (Pubitemid 46646428)
28. Silvast TS, Jurvelin JS, Aula AS, et al. 2009. Contrast agent-enhanced computed tomography of articular cartilage: association with tissue composition and properties. Acta Radiol 50: 78-85.
29. Silvast TS, Jurvelin JS, Lammi MJ, et al. 2009. pQCT study on diffusion and equilibrium distribution of iodinated anionic contrast agent in human articular cartilage-associations to matrix composition and integrity. Osteoarthritis Cartilage 17: 26-32.
30. Bansal PN, Joshi NS, Entezari V, et al. 2010. Contrast enhanced computed tomography can predict the glycosaminoglycan content of and biomechanical properties of articular cartilage. Osteoarthritis Cartilage 18: 184-189.
31. Winalski CS, Shortkroff S, Mulkern RV, et al. 2002. Magnetic resonance relaxivity of dendrimer-linked nitroxides. Magn Reson Med 48: 965-972. (Pubitemid 35398525)
32. Yin M, Shen J, Pflugfelder GO, et al. 2008. A fluorescent core-shell dendritic macromolecule specifically stains the extracellular matrix. J Am Chem Soc 130: 7806-7807. (Pubitemid 351875039)
33. Van Ootegham SP, Smith RG, Daves GD Jr, et al. 1976. Iodo-bis(quaternary ammonium) salts. Potential cartilage-selective X-ray contrast agents. J Med Chem 19: 1349-1352.
34. Giraud I, Rapp M, Maurizis JC, et al. 2000. Application to a cartilage targeting strategy: synthesis and in vivo biodistribution of C-14-labeled quaternary ammonium-glucosamine conjugates. Bioconjug Chem 11: 212-218. (Pubitemid 30174488)
35. Joshi NS, Bansal PN, Stewart RC, et al. 2009. The effect of contrast agent charge on visualization of articular cartilage using computed tomography: exploiting electrostatic interactions for improved sensitivity. J Am Chem Soc 131: 13234-13235.
36. Farndale RW, Sayers CA, Barrett AJ, et al. 1982. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 9: 247-248. (Pubitemid 12009669)
37. Chen CT, Fishbein KW, Torzilli PA, et al. 2003. Matrix fixed-charge density as determined by magnetic resonance microscopy of bioreactor-derived hyaline cartilage correlates with biochemical and biomechanical properties. Arthritis Rheum 48: 1047-1056. (Pubitemid 36418247)
38. Asanbaeva A, Masuda K, Thonar EJ, et al. 2007. Mechanisms of cartilage growth: modulation of balance between proteoglycan and collagen in vitro using chondroitinase ABC. Arthritis Rheum 56: 188-198. (Pubitemid 46106191)